Electrophoresis 2007-08-01

Fast quantitative determination of diuretic drugs in tablets and human urine by microchip electrophoresis with native fluorescence detection.

Kamal Tolba, Detlev Belder

Index: Electrophoresis 28(16) , 2934-41, (2007)

Full Text: HTML

Abstract

Microchip electrophoresis (MCE) with native fluorescence detection has been applied for the fast quantitative analysis of pharmaceutical formulations. For this purpose, methods for fast separation and sensitive detection of the unlabeled diuretic drugs, amiloride, triamterene, bendroflumethiazide (BFMTZ), and bumetanide were developed. An epifluorescence setup was used enabling the coupling of different lasers into a commercial fluorescence microscope. The detection sensitivity of different excitation light sources was compared utilizing either a HeCd laser (lambda(exc) = 325 nm), a frequency quadrupled Nd:YAG laser (lambda(exc) = 266 nm), or a mercury lamp (lambda(exc) = 330-380 nm). At optimal conditions using the HeCd laser, the drugs were separated within 15 s with LODs less than 1 mug/mL for the four compounds. A linear relationship between concentration and peak area was obtained in the concentration range of 0.05-20 microg/mL with a mean correlation coefficient of around 0.996 for all analytes. The method was successfully applied to the analysis of the respective drugs in commercial formulations and in human urine without interference from other constituents. These data show that MCE has a great potential for reliable drug analysis.


Related Compounds

Related Articles:

[Clinical strategies for prevention of drug-induced urinary calculi].

2011-10-01

[Clin. Calcium 21(10) , 1457-63, (2011)]

Bioavailability study of triamterene and xipamide using urinary pharmacokinetic data following single oral dose of each drug or their combination.

2012-03-05

[J. Pharm. Biomed. Anal. 61 , 78-85, (2012)]

Spectrophotometric and spectrodensitometric determination of triamterene and xipamide in pure form and in pharmaceutical formulation.

2010-03-01

[Drug Test. Anal. 2(3) , 113-21, (2010)]

A new resorufin-based alpha-glucosidase assay for high-throughput screening.

2009-07-01

[Anal. Biochem. 390 , 79-84, (2009)]

Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.

2012-06-01

[Am. J. Trop. Med. Hyg. 86(6) , 931-5, (2012)]

More Articles...